ARQT · Categories · Downgrades

ARQT - Analyst downgrades

Arcutis Biotherapeutics Inc. (ARQT) analyst downgrades - real-time wire coverage filtered to Downgrades only.

Recent Downgrades for ARQT

• 995d
  Arcutis Biotherapeutics downgraded by Mizuho with a new price target

  Mizuho downgraded Arcutis Biotherapeutics from Buy to Neutral and set a new price target of $4.00 from $57.00 previously
• 1008d
  Arcutis Biotherapeutics downgraded by Goldman with a new price target

  Goldman downgraded Arcutis Biotherapeutics from Buy to Neutral and set a new price target of $6.00 from $32.00 previously

Other ARQT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings